Veterinary Medicines

Cefabactin 50 mg tablets for dogs and cats

Not authorised
  • Cefalexin monohydrate
Download as PDF

Product identification

Medicine name:
Cefabactin 50 mg tablets for dogs and cats
Cefatab flavour 50 mg Tabletten für Hunde und Katzen
Active substance:
  • Cefalexin monohydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    52.50
    milligram(s)
    /
    1.00
    Piece
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Germany
Package description:
  • Cardboard box of 10 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 4 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 3 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 25 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 2 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 7 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 6 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 5 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 9 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 8 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 1 blister (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402256.00.00
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0201/001
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."